Literature DB >> 19370804

Functional imaging of head and neck cancers.

Patrick Emonts1, Pierre Bourgeois, Marc Lemort, Patrick Flamen.   

Abstract

PURPOSE OF REVIEW: Functional imaging including single photon emission computed tomography, PET and MRI techniques in head and neck squamous cell cancer allows disease characterization beyond structure and morphology. RECENT
FINDINGS: In patients without clinical signs of lymph node involvement, sensitivity of fluoro-2-deoxy-D-glucose PET is only 50%. This has led to the use of sentinel lymph node scintigraphy that seems to be a valid alternative to elective stage dissection. Additionally, the use of single-photon emission computed tomography-computed tomography imaging enables a more accurate localization of the sentinel lymph node scintigraphy. The fluoro-2-deoxy-D-glucose uptake intensity of the head and neck squamous cell carcinoma sites is related to locoregional control and overall survival. In case of suspicion for residual or recurrent head and neck squamous cell carcinoma after surgery or (chemo)radiotherapy, fluoro-2-deoxy-D-glucose-PET has a high sensitivity and seems to be cost-effective in selecting patients for direct laryngoscopy. Diffusion-weighted MRI in combination with size and morphological criteria is a strong predictor of presence of malignant lymph nodes. Initial reports indicate the use of diffusion-weighted imaging for response assessment as early as 1 week after beginning of radiochemotherapy. Perfusion MRI is studied for the measurement of drug effects on tumour (micro)vascularity and capillary permeability.
SUMMARY: Functional imaging improves the initial staging and the detection of residual or recurrent disease following therapy.

Entities:  

Mesh:

Year:  2009        PMID: 19370804     DOI: 10.1097/cco.0b013e32832a2322

Source DB:  PubMed          Journal:  Curr Opin Oncol        ISSN: 1040-8746            Impact factor:   3.645


  2 in total

1.  Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Authors:  Amita Shukla-Dave; Nancy Y Lee; Jacobus F A Jansen; Howard T Thaler; Hilda E Stambuk; Matthew G Fury; Snehal G Patel; Andre L Moreira; Eric Sherman; Sasan Karimi; Ya Wang; Dennis Kraus; Jatin P Shah; David G Pfister; Jason A Koutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-19       Impact factor: 7.038

2.  Head and neck cancer: value of perfusion CT in depicting primary tumor spread.

Authors:  Agnieszka Trojanowska; Piotr Trojanowski; Andrzej Drop; Tomasz Jargiełło; Janusz Klatka
Journal:  Med Sci Monit       Date:  2012-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.